7,638.50

+24.50

+0.32%

52,124.00

+206.00

+0.40%

28,698.25

+164.25

+0.58%

Russell 2000 Futures

2,833.70

+12.40

+0.44%

4.9170

-0.0120

-0.24%

19.55

+0.13

+0.67%

3,921.00

+22.10

+0.57%

78,031.74

+138.65

+0.18%

Crude Oil Dec 26

99.76

-4.36

-4.19%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

Edesa Biotech, Inc. (EDSA)

2.5700 -0.1100 (-4.10%)

At close: October 30 at 4:00:01 PM EDT

2.5870 +0.0170 (+0.66%)

Pre-Market: 7:51:03 AM EST

Loading Chart for EDSA

Chart Range Bar

Interval:

In partnership with ChartIQ

Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway

EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway

Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech Announces Proposed Public Offering

Edesa Biotech Announces Proposed Public Offering

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

EDSA: Positive Exploratory Data in Patients with AKI

EDSA: Positive Exploratory Data in Patients with AKI

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

Mobilize your Website

View Site in Mobile | Classic

Share by: